|
Originally published In Press as doi:10.1074/jbc.M208956200 on October 10, 2002
J. Biol. Chem., Vol. 277, Issue 52, 50629-50635, December 27, 2002
Mapping the Heparin-binding Site on the
13-14F3 Fragment of Fibronectin*
Sachchidanand ,
Olivier
Lequin §,
David
Staunton¶,
Barbara
Mulloy ,
Mark J.
Forster ,
Keiichi
Yoshida**, and
Iain D.
Campbell ¶
From the Department of Biochemistry and ¶ Oxford
Centre for Molecular Sciences, University of Oxford, South Parks Rd.,
Oxford OX1 3QU, United Kingdom, National Institute for
Biological Standards and Control, Blanche Lane, South Mimms,
Potters Bar, Herts EN6 3QG, United Kingdom, and ** Mizutani
Foundation for Glycoscience, 3-1-11 Nihonbashi-honcho, Chuo-ku,
Tokyo 103-0023, Japan
Fibronectin, a multifunctional
glycoprotein of the extracellular matrix, plays a major role in cell
adhesion. Various studies have revealed that the human 13th and 14th
fibronectin type III domains (labeled 13F3 and
14F3 here) contain a heparin-binding site. Mapping of the
heparin-binding sites of 13-14F3, 13F3, and
14F3 by NMR chemical shift perturbation, isothermal
titration calorimetry, and molecular modeling show that
13F3 provides the dominant heparin-binding site and that
the residues involved are within the first 29 amino acids of
13F3. Predictions from earlier biochemical and modeling
studies as well as the x-ray structure of 12-14F3 were
tested. It was shown that the positively charged residues that project
into the solvent from the ABE face of the triple-stranded sheet on
13F3 are involved in binding, but 14F3 does not
appear to contribute significantly to heparin binding.
*
This work was supported by the Felix Foundation (to S.), the
Federation of European Biochemical Societies (to O. L.), and the
Wellcome Trust (to D. S. and I. D. C.). This is a contribution from
the Oxford Centre for Molecular Sciences, which is supported by the
Biotechnology and Biological Sciences Research Council, Swindon, the
Medical Research Council, and The Engineering and Physical Sciences
Research Council, United Kingdom.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: Laboratoire de Chimie Structurale Organique et
Biologique (UMR 7613), Université Pierre et Marie Curie, Bat F74,
Boite 45, 4 place Jussieu, 75252, Paris Cedex 05, France.

To whom correspondence should be addressed. Tel.:
44-1865-275990; Fax: 44-1865-275905; E-mail: idc@bioch.ox.ac.uk.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Mitsi, K. Forsten-Williams, M. Gopalakrishnan, and M. A. Nugent
A Catalytic Role of Heparin within the Extracellular Matrix
J. Biol. Chem.,
December 12, 2008;
283(50):
34796 - 34807.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L DeMarco and R. J Woods
Structural glycobiology: A game of snakes and ladders
Glycobiology,
June 1, 2008;
18(6):
426 - 440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Castelletti, R. Donadelli, F. Banterla, F. Hildebrandt, P. F. Zipfel, E. Bresin, E. Otto, C. Skerka, A. Renieri, M. Todeschini, et al.
Mutations in FN1 cause glomerulopathy with fibronectin deposits
PNAS,
February 19, 2008;
105(7):
2538 - 2543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Mahalingam, J. T. Gallagher, and J. R. Couchman
Cellular Adhesion Responses to the Heparin-binding (HepII) Domain of Fibronectin Require Heparan Sulfate with Specific Properties
J. Biol. Chem.,
February 2, 2007;
282(5):
3221 - 3230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Dabo, A. W. Confer, B. E. Anderson, and S. Gupta
Bartonella henselae Pap31, an Extracellular Matrix Adhesin, Binds the Fibronectin Repeat III13 Module.
Infect. Immun.,
May 1, 2006;
74(5):
2513 - 2521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Mahoney, B. Mulloy, M. J. Forster, C. D. Blundell, E. Fries, C. M Milner, and A. J. Day
Characterization of the Interaction between Tumor Necrosis Factor-stimulated Gene-6 and Heparin: IMPLICATIONS FOR THE INHIBITION OF PLASMIN IN EXTRACELLULAR MATRIX MICROENVIRONMENTS
J. Biol. Chem.,
July 22, 2005;
280(29):
27044 - 27055.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Peterson, N. Sheibani, G. David, A. Garcia-Pardo, and D. M. Peters
Heparin II Domain of Fibronectin Uses {alpha}4{beta}1 Integrin to Control Focal Adhesion and Stress Fiber Formation, Independent of Syndecan-4
J. Biol. Chem.,
February 25, 2005;
280(8):
6915 - 6922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bossard, L. V. d. Berghe, H. Laurell, C. Castano, M. Cerutti, A.-C. Prats, and H. Prats
Antiangiogenic Properties of Fibstatin, an Extracellular FGF-2-Binding Polypeptide
Cancer Res.,
October 15, 2004;
64(20):
7507 - 7512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gao, D. Craig, O. Lequin, I. D. Campbell, V. Vogel, and K. Schulten
Structure and functional significance of mechanically unfolded fibronectin type III1 intermediates
PNAS,
December 9, 2003;
100(25):
14784 - 14789.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|